A novel Chk1/2-Lats2-14-3-3 signaling pathway regulates P-body formation in response to UV damage

Journal of Cell Science

Volumn 124, Issue 1, 2011, Pages 57-67

  Okada, Nobuhiro ^a   Yabuta, Norikazu ^a   Suzuki, Hirokazu ^a   Aylon, Yael ^b   Oren, Moshe ^b   Nojima, Hiroshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

14 3 3; Chk1; DNA damage; Lats Warts; P body

Indexed keywords

CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; PROTEIN 14 3 3; PROTEIN LATS1; PROTEIN LATS2; SERINE; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; ENZYME PHOSPHORYLATION; GENOME; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; ULTRAVIOLET RADIATION;

14-3-3 PROTEINS; CELL LINE; DNA DAMAGE; HUMANS; ORGANELLES; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RADIATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

MAMMALIA;

EID: 78651100655     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.072918     Document Type: Article

References (44)

1. Aitken, A. (2006). 14-3-3 proteins: a historic overview. Semin. Cancer Biol. 16, 162-172.
2. Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H. and Oren, M. (2006). A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20, 2687-2700. (Pubitemid 44498379)
3. Aylon, Y., Yabuta, N., Besserglick, H., Buganim, Y., Rotter, V., Nojima, H. and Oren, M. (2009). Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation. Oncogene 28, 4469-4479.
4. Bartek, J. and Lukas, J. (2003). Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421-429.
5. Bartek, J., Bartkova, J. and Lukas, J. (2007). DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26, 7773-7779.
6. Carthew, R. W. and Sontheimer, E. J. (2009). Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655.
7. Cimprich, K. A. and Cortez, D. (2008). ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 9, 16-27.
8. Ding, L. and Han, M. (2007). GW182 family proteins are crucial for microRNA-mediated gene silencing. Trends Cell Biol. 17, 411-416.
9. Esquela-Kerscher, A. and Slack, F. J. (2006). Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
10. Eulalio, A., Behm-Ansmant, I. and Izaurralde, E. (2007). P bodies: at the crossroads of post-transcriptional pathways. Nat. Rev. Mol. Cell Biol. 8, 9-22.
11. Eystathioy, T., Chan, E. K., Tenenbaum, S. A., Keene, J. D., Griffith, K. and Fritzler, M. J. (2002). A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol. Biol. Cell 13, 1338-1351.
12. Finkin, S., Aylon, Y., Anzi, S., Oren, M. and Shaulian, E. (2008). Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy. Oncogene 27, 4411-4421.
13. Franks, T. M. and Lykke-Andersen, J. (2008). The control of mRNA decapping and P-body formation. Mol. Cell 32, 605-615.
14. Grusche, F. A., Richardson, H. E. and Harvey, K. F. (2010). Upstream regulation of the hippo size control pathway. Curr. Biol. 20, R574-R582.
15. Hutvagner, G. and Simard, M. J. (2008). Argonaute proteins: key players in RNA silencing. Nat. Rev. Mol. Cell Biol. 9, 22-32.
16. Jakymiw, A., Lian, S., Eystathioy, T., Li, S., Satoh, M., Hamel, J. C., Fritzler, M. J. and Chan, E. K. (2005). Disruption of GW bodies impairs mammalian RNA interference. Nat. Cell Biol. 7, 1267-1274.
17. Jakymiw, A., Pauley, K. M., Li, S., Ikeda, K., Lian, S., Eystathioy, T., Satoh, M., Fritzler, M. J. and Chan, E. K. (2007). The role of GW/P-bodies in RNA processing and silencing. J. Cell Sci. 120, 1317-1323.
18. Kamikubo, Y., Takaori-Kondo, A., Uchiyama, T. and Hori, T. (2003). Inhibition of cell growth by conditional expression of kpm, a human homologue of Drosophila warts/lats tumor suppressor. J. Biol. Chem. 278, 17609-17614.
19. Kastan, M. B. and Bartek, J. (2004). Cell-cycle checkpoints and cancer. Nature 432, 316-323.
20. Kawahara, M., Hori, T., Chonabayashi, K., Oka, T., Sudol, M. and Uchiyama, T. (2008). Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73. Blood 112, 3856-3866.
21. Ke, H., Pei, J., Ni, Z., Xia, H., Qi, H., Woods, T., Kelekar, A. and Tao, W. (2004). Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L). Exp. Cell Res. 298, 329-338.
22. Kim, V. N., Han, J. and Siomi, M. C. (2009). Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139.
23. Lavin, M. F. (2008). Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 9, 759-769.
24. Leung, A. K., Calabrese, J. M. and Sharp, P. A. (2006). Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc. Natl. Acad. Sci. USA 103, 8125-8130.
25. Li, Y., Pei, J., Xia, H., Ke, H., Wang, H. and Tao, W. (2003). Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 22, 4398-4405. (Pubitemid 36897970)
26. Liu, J., Rivas, F. V., Wohlschlegel, J., Yates, J. R., 3rd, Parker, R. and Hannon, G. J. (2005). A role for the P-body component GW182 in microRNA function. Nat. Cell Biol. 7, 1261-1266.
27. Löbrich, M. and Jeggo, P. A. (2007). The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat. Rev. Cancer 7, 861-869.
28. Mah, A. S., Elia, A. E., Devgan, G., Ptacek, J., Schutkowski, M., Snyder, M., Yaffe, M. B. and Deshaies, R. J. (2005). Substrate specificity analysis of protein kinase complex Dbf2-Mob1 by peptide library and proteome array screening. BMC Biochem. 21, 6-22.
29. McNeill, H. and Woodgett, J. R. (2010). When pathways collide: collaboration and connivance among signalling proteins in development. Nat. Rev. Mol. Cell Biol. 11, 404-413.
30. McPherson, J. P., Tamblyn, L., Elia, A., Migon, E., Shehabeldin, A., Matysiak-Zablocki, E., Lemmers, B., Salmena, L., Hakem, A., Fish, J. et al. (2004). Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 23, 3677-3688.
31. Morrison, D. K. (2009). The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19, 16-23.
32. Nagamori, I., Yabuta, N., Fujii, T., Tanaka, H., Yomogida, K., Nishimune, Y. and Nojima, H. (2005). Tisp40, a spermatid specific CREM-like transcription factor, functions through unfolded protein response element via Rip pathway. Genes Cells 10, 75-94.
33. Oka, T., Mazack, V. and Sudol, M. (2008). Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J. Biol. Chem. 283, 27534-27546.
34. O'Neill, T., Giarratani, L., Chen, P., Iyer, L., Lee, C. H., Bobiak, M., Kanai, F., Zhou, B. B., Chung, J. H. and Rathbun, G. A. (2002). Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J. Biol. Chem. 277, 16102-16115.
35. Sen, G. L. and Blau, H. M. (2005). Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat. Cell Biol. 7, 633-636.
36. Sharp, P. A. (2009). The centrality of RNA. Cell 136, 577-580.
37. Strano, S., Monti, O., Pediconi, N., Baccarini, A., Fontemaggi, G., Lapi, E., Mantovani, F., Damalas, A., Citro, G., Sacchi, A. et al. (2005). The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol. Cell 18, 447-459.
38. Teixeira, D., Sheth, U., Valencia-Sanchez, M. A., Brengues, M. and Parker, R. (2005). Processing bodies require RNA for assembly and contain nontranslating mRNAs. RNA 11, 371-382.
39. Toji, S., Yabuta, N., Hosomi, T., Nishihara, S., Kobayashi, T., Suzuki, S., Tamai, K. and Nojima, H. (2004). The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase. Genes Cells 9, 383-397. (Pubitemid 38771930)
40. Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J., Stoop, H., Nagel, R., Liu, Y. P., van Duijse, J., Drost, J., Griekspoor, A. et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169-1181.
41. Yabuta, N., Onda, H., Watanabe, M., Yoshioka, N., Nagamori, I., Funatsu, T., Toji, S., Tamai, K. and Nojima, H. (2006). Isolation and characterization of the TIGA genes, whose transcripts are induced by growth arrest. Nuc. Acids Res. 34, 4878-4892.
42. Yabuta, N., Okada, N., Ito, A., Hosomi, T., Nishihara, S., Sasayama, Y., Fujimori, A., Okuzaki, D., Zhao, H., Ikawa, M. et al. (2007). Lats2 is an essential mitotic regulator required for the coordination of cell division. J. Biol. Chem. 282, 19259-19271.
43. Yee, C., Krishnan-Hewlett, I., Baker, C. C., Schlegel, R. and Howley, P. M. (1985). Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119, 361-366.
44. Zeng, Y., Sankala, H., Zhang, X. and Graves, P. R. (2008). Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. Biochem. J. 413, 429-436.